A detailed history of Albion Financial Group transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Albion Financial Group holds 1,985 shares of BMY stock, worth $79,519. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,985
Previous 1,241 59.95%
Holding current value
$79,519
Previous $63,000 69.84%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$47.98 - $54.4 $35,697 - $40,473
744 Added 59.95%
1,985 $107,000
Q4 2023

Jan 26, 2024

BUY
$48.48 - $57.85 $1,987 - $2,371
41 Added 3.42%
1,241 $63,000
Q4 2022

Feb 03, 2023

SELL
$68.48 - $81.09 $16,777 - $19,867
-245 Reduced 16.96%
1,200 $86,000
Q3 2022

Oct 27, 2022

SELL
$0.13 - $76.84 $52 - $31,043
-404 Reduced 21.85%
1,445 $103,000
Q2 2022

Jul 29, 2022

BUY
$72.62 - $79.98 $72 - $79
1 Added 0.05%
1,849 $142,000
Q1 2022

May 09, 2022

BUY
$61.48 - $73.72 $61 - $73
1 Added 0.05%
1,848 $135,000
Q4 2021

Feb 15, 2022

SELL
$53.63 - $62.52 $21,398 - $24,945
-399 Reduced 17.76%
1,847 $115,000
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $123 - $134
2 Added 0.09%
2,246 $150,000
Q4 2020

Feb 19, 2021

BUY
$57.74 - $65.43 $129,568 - $146,824
2,244 New
2,244 $139,000
Q4 2018

Jan 28, 2019

SELL
$48.76 - $63.23 $2.36 Million - $3.07 Million
-48,476 Closed
0 $0
Q3 2018

Nov 20, 2018

SELL
$55.19 - $62.25 $167,391 - $188,804
-3,033 Reduced 5.89%
48,476 $3.01 Million
Q2 2018

Aug 15, 2018

BUY
$50.53 - $62.98 $11,874 - $14,800
235 Added 0.46%
51,509 $2.85 Million
Q1 2018

Apr 17, 2018

SELL
$59.92 - $68.98 $13,721 - $15,796
-229 Reduced 0.44%
51,274 $3.24 Million
Q4 2017

Feb 22, 2018

SELL
$59.94 - $65.35 $17,322 - $18,886
-289 Reduced 0.56%
51,503 $3.16 Million
Q3 2017

Nov 09, 2017

BUY
$55.23 - $63.74 $1.54 Million - $1.78 Million
27,960 Added 117.32%
51,792 $3.3 Million
Q2 2017

Aug 15, 2017

BUY
N/A
23,832
23,832 $1.33 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $85.2B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Albion Financial Group Portfolio

Follow Albion Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

News

Stay updated on Albion Financial Group with notifications on news.